These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37173988)
21. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study. He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630 [TBL] [Abstract][Full Text] [Related]
22. Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer. Yang Y; Chen M; Xie J; Ji Y; Sheng L; Qiu G; Du X; Wei Q Front Oncol; 2022; 12():778898. PubMed ID: 35237508 [TBL] [Abstract][Full Text] [Related]
23. Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach. You MS; Ryu JK; Huh G; Chun JW; Paik WH; Lee SH; Kim YT World J Clin Oncol; 2020 Sep; 11(9):747-760. PubMed ID: 33033696 [TBL] [Abstract][Full Text] [Related]
26. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy. Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577 [TBL] [Abstract][Full Text] [Related]
27. Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab - An exploratory study. Wiley RL; Bondre IL; Jalloul R; Klopp AH; Taylor JS; Ramondetta LM Gynecol Oncol Rep; 2022 Apr; 40():100963. PubMed ID: 35345549 [TBL] [Abstract][Full Text] [Related]
28. Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy. Wang R; Zhou X; Liu T; Lin S; Wang Y; Deng X; Wang W Front Oncol; 2022; 12():898383. PubMed ID: 35747837 [TBL] [Abstract][Full Text] [Related]
29. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study. Zhao Q; Hu G; Xiao W; Chen Y; Shen M; Tang Q; Ning X Medicine (Baltimore); 2017 Sep; 96(35):e7920. PubMed ID: 28858114 [TBL] [Abstract][Full Text] [Related]
30. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery. Valmasoni M; Pierobon ES; Zanchettin G; Briscolini D; Moletta L; Ruol A; Salvador R; Merigliano S Ann Surg Oncol; 2018 Sep; 25(9):2747-2755. PubMed ID: 29987601 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study. Yamashita H; Takenaka R; Okuma K; Ootomo K; Nakagawa K Thorac Cancer; 2016 Sep; 7(5):564-569. PubMed ID: 27766787 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma. Shi Z; Zhu X; Ruan C; Wei G; Li J; Qiu H; Gao L; Cai G; Zhangcai Y; Li B; Wang J; Gong Y; Chen J; Zhao W; Wu Y; Ke S; Chen Y JAMA Netw Open; 2022 Dec; 5(12):e2244619. PubMed ID: 36454568 [TBL] [Abstract][Full Text] [Related]
33. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery? Tougeron D; Scotté M; Hamidou H; Di Fiore F; Paillot B; Michot F; Michel P J Surg Oncol; 2012 Jun; 105(8):761-6. PubMed ID: 22124932 [TBL] [Abstract][Full Text] [Related]
34. Impact of radiotherapy, chemotherapy and surgery in multimodal treatment of locally advanced esophageal cancer. Berger B; Stahlberg K; Lemminger A; Bleif M; Belka C; Bamberg M Oncology; 2011; 81(5-6):387-94. PubMed ID: 22269965 [TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study. Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449 [TBL] [Abstract][Full Text] [Related]
36. The Role of Definitive Radiation and Surgery in Metastatic Esophageal Cancer: An NCDB Investigation. Seyedin SN; Parekh KR; Ginader T; Caster JM Ann Thorac Surg; 2021 Aug; 112(2):459-466. PubMed ID: 33096068 [TBL] [Abstract][Full Text] [Related]
38. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. Kelly JR; Park HS; An Y; Contessa JN; Yarbrough WG; Burtness BA; Decker R; Husain Z JAMA Oncol; 2017 Aug; 3(8):1107-1111. PubMed ID: 28056116 [TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity. Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885 [TBL] [Abstract][Full Text] [Related]
40. Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC. Farooqi A; Ludmir EB; Mitchell KG; Antonoff MB; Tang C; Lee P; Chang J; Elamin Y; Gomez DR; Gandhi SJ Radiother Oncol; 2021 Oct; 163():114-118. PubMed ID: 34419505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]